Platelets harness innate immunity to promote the dissemination of HCC
- 29 May 2024
- journal article
- editorial
- Published by Wolters Kluwer Health in Hepatology
- Vol. 81 (3) , 757-759
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 13 references indexed in Scilit:
- Platelet count as a predictor of vascular invasion and extrahepatic metastasis in hepatocellular carcinoma: A systematic review and meta-analysisHeliyon, 2024
- Weaponizing natural killer cells for solid cancer immunotherapyTrends in Cancer, 2022
- Evolving therapeutic landscape of advanced hepatocellular carcinomaNature Reviews Gastroenterology & Hepatology, 2022
- Global burden of primary liver cancer in 2020 and predictions to 2040Journal of Hepatology, 2022
- Platelets control liver tumor growth through P2Y12-dependent CD40L release in NAFLDCancer Cell, 2022
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology, 2021
- NASH limits anti-tumour surveillance in immunotherapy-treated HCCNature, 2021
- Molecular principles of metastasis: a hallmark of cancer revisitedSignal Transduction and Targeted Therapy, 2020
- Risk of posttransplant hepatocellular carcinoma recurrence is greater in recipients with higher platelet counts in living donor liver transplantationLiver Transplantation, 2017
- Control of Metastasis by NK CellsCancer Cell, 2017